10:34 AM EDT, 08/04/2025 (MT Newswires) -- (Updates with recent stock move in headline and first paragraph.)

IDEXX Laboratories ( IDXX ) shares were up 24% in recent trading Monday after the company posted stronger-than-expected Q2 earnings and revenue, and boosted its 2025 guidance.

The company reported Q2 earnings Monday of $3.63 per diluted share, up from $2.44 a year earlier.

Analysts polled by FactSet expected $3.30 per share.

Revenue for the quarter ended June 30 was $1.11 billion, compared with $1.00 billion a year earlier.

Analysts surveyed by FactSet expected $1.07 billion.

For 2025, the company now expects earnings in the range of $12.40 to $12.76 per share, up from a prior guidance of $11.93 to $12.43. Analysts polled by FactSet expect $12.21.

Revenue for 2025 is projected to be between $4.21 billion and $4.28 billion, compared with a prior outlook of $4.10 billion to $4.21 billion. Analysts surveyed by FactSet expect $4.15 billion.

Price: 664.30, Change: +128.76, Percent Change: +24.04